SOON

PDOHub™ Hong Kong is the Asia’s First Integrated Organoid‑Based Precision Medicine Centre, established by BiomOrgan and InnoHK Centre for Virology, Vaccinology, and Therapeutics (CVVT) to bring advanced organoid technology into real‑world applications. We serve as a dedicated hub for developing, validating, and deploying patient‑derived organoid (PDO) platforms across oncology, infectious diseases, and emerging health challenges.

​

​PDOHub™ Hong Kong 係亞洲首個整合式類器官精準醫學中心，由BiomOrgan及InnoHK「病毒與疫苗研究中心」（CVVT）共同成立，旨在將先進類器官技術帶入實際應用。 我們致力成為一個專門平台，用於開發、驗證及部署病人來源類器官（PDO）技術，涵蓋腫瘤、傳染病，以及新興健康挑戰等多個領域。